AbbVie announces €60m expansion at Cork manufacturing site
AbbVie, a research and development-based biopharmaceutical company with a significant presence across eight Irish locations, will invest €60 million in its manufacturing site in Co. Cork.
The expansion, which will include the development of a new state-of-the-art facility, will create approximately 70 new jobs. The new roles will be spread across various areas including sterile manufacturing, quality control, and engineering.
Commenting on the announcement Malcolm Garde, site director, AbbVie Cork, said: “This latest investment is a fantastic opportunity for the Cork site and a recognition of the expertise and commitment of our dedicated employees over the past 20 years. The expansion and associated cutting-edge technologies will help us to further develop our employees and attract new skilled talent.”
IDA Ireland CEO Martin Shanahan said: “This latest investment by AbbVie is testament to Ireland being an attractive and supportive location for continued investment by established companies. Marking two decades of successful operations at its manufacturing site in Carrigtwohill by making a further €60 million investment, creating 70 additional jobs, is a strong endorsement and demonstrates a clear commitment to the company’s Cork site.
“It’s a very significant day for a plant that already has a long and proud record of pharmaceutical manufacturing and innovation. IDA Ireland is delighted to partner with AbbVie in creating these opportunities for new employees who will help write the next chapter in its story.”
AbbVie employs approximately 2,600 people at seven other locations across Ireland including Sligo, Mayo, and Dublin. The company has been recognised as one of the Best Large Workplaces in Ireland for the past nine years and was named as a Best Workplace for Women earlier this year. AbbVie was also named ‘Biopharma Company of the Year’ at the most recent Irish Pharma Industry Awards.
TechCentral Reporters
Subscribers 0
Fans 0
Followers 0
Followers